Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Friday, 29th October 2021 to approve and take on record unaudited consolidated & standalone Financial Results of the Company for the second quarter and half year ended 30th September 2021, consider declaration of interim dividend, if any, for the financial year ending 31st March 2022, and fixation of Wednesday, 10th November 2021 as the Record Date for the payment of interim dividend, if declared.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: